Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
The F.D.A.’s new limited approval covers two vaccines designed with mRNA that were updated to target the LP.8.1 variant, which represents nearly one-third of recent cases.
- Simplified Text
-
FDA's new approval covers mRNA vaccines updated for LP.8.1 variant representing one-third of cases
- Confidence Score
- 0.500
- Claim Maker
- Christina Jewett, Jacey Fortin
- Context Type
- Website Article
- Context Details
-
{ "date": null } - Subject Tags
- UUID
- 9fc8b090-da7c-47e2-93df-50c7c2bfcda9
- Vector Index
- ✗ No vector
- Created
- September 2, 2025 at 7:57 PM (6 days ago)
- Last Updated
- September 2, 2025 at 7:57 PM (6 days ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
33
claims
🔥
6 days ago
https://www.nytimes.com/2025/08/27/health/fda-covid-vaccines-rfk-jr.html?campaign_id=9&emc=edit_nn_20250828&instance_id=161436&nl=the-morning®i_id=122976029&segment_id=204795&user_id=b25c5730c89e0c73f75709d8f1254337
The FDA approved updated Covid vaccines with eligibility limited to those 65+ or with underlying conditions. This decision, influenced by Robert F. Kennedy Jr.'s changes to the CDC advisory panel, sparked controversy among health experts.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.